December 2025 Newsletter: Pharmalys wishes you a happy festive season!

Dec 11, 2025 | Newsletters

As we approach the end of the year, we would like to take a moment to reflect on what has been a significant and impactful 2025 for Pharmalys. This year marked an important milestone with Pharmalys taking over operations of the GCLP accreditation scheme from Tim Stiles, one of the original authors of the GCLP guidelines, following two years of close collaboration. This transition reinforces our long-standing commitment to strengthening laboratory quality across the globe, supporting organisations in achieving robust, sustainable standards.

Across 2025, we also supported and delivered multiple clinical trials in diverse settings, often under challenging conditions. Whether navigating politically unstable environments, managing safety constraints during site visits, or identifying compliant solutions where infrastructure was limited, our teams worked with resilience, adaptability, and unwavering focus on quality.

Capacity building remained a central pillar of our mission. This year, we expanded our work to reinforce knowledge and skills across the clinical research ecosystem, from clinical research professionals to Ethics Committees and Regulatory Authorities. Through targeted training and hands-on workshops across regions, we continued to support stronger, more sustainable systems for ethical and high-quality clinical research.

None of this would have been possible without our exceptional team, whose work across countries and time zones has been at the heart of every achievement. We extend our sincere thanks to all who have worked with us, supported our programmes, or contributed to shared progress throughout the year.

As we close 2025, we wish you a restful and enjoyable festive season, and we look forward to continuing our mission together in the new year to Count Africa In.

Pharmalys CEO Marieme Ba Honoured as an IMPACT WOMAN at Alumni Day 2025

In September 2025, the Ecole Supérieure Polytechnique (ESP) Alumni community gathered at the Azalaï Hotel in Dakar, Senegal, to celebrate Alumni Day, a moment to recognise excellence, leadership, and contribution to society. Among the distinguished honourees was Marieme Ba, CEO and Founder of Pharmalys, who received an IMPACT WOMAN award.

The IMPACT WOMAN category shines a spotlight on alumni who exemplify commitment, leadership, and high-impact action in their fields. Marieme’s recognition reflects not only her achievements as an entrepreneur but also her transformative vision for health research in Africa.

A Leader in Science and Social Responsibility

Marieme founded Pharmalys with a clear mission: to bridge critical gaps and sustain quality in clinical research across Sub-Saharan Africa. In regions where underdeveloped research infrastructure limits progress and policy, Pharmalys has worked to strengthen systems, build capacity, and advocate for inclusivity.

For over a decade, the company has partnered with health authorities, ethics committees, universities, and non-profits to raise awareness, identify systemic gaps, and establish standards of excellence in clinical research across Africa.

Beyond its scientific achievements, Pharmalys is deeply rooted in social responsibility.

Read the full article and learn more on our actions in social responsibility here.

 

Project Management and Delivery by Pharmalys

Turning complexity into clarity for your projects

Our Project Managers bring PMI methodologies together with deep therapeutic, regulatory, and regional expertise. They don’t just coordinate tasks, they drive projects forward with structure, foresight, and accountability.

What Sets Our Project Managers Apart

  • Strategic alignment of study delivery with scientific and regulatory requirements
  • Certified proficiency in PMI techniques, ICH-GCP, and global quality frameworks
  • Proactive risk identification and mitigation
  • Clear, consistent communication that keeps stakeholders aligned
  • Strong leadership of multidisciplinary teams
  • Constructive management of challenges and conflict
  • Proven understanding of Africa’s clinical landscape and regulatory pathways
  • Culturally informed engagement across diverse teams and sites

Learn more

Benefits for Our Clients

  • On-time, on-budget delivery: Timelines and resources managed with discipline and transparency.
  • Reduced risk: Early identification and effective mitigation of potential issues.
  • Consistent quality: Harmonised standards across countries, sites, and vendors.
  • Stronger partnerships: Clear communication that builds alignment and trust.
  • Reliable results: Data integrity and regulatory compliance maintained from start to finish.

Contact Us

The Flexibiltiy of Outsourcing and the Reliability of Leadership

with the Pharmalys Fuctional Service Provider

Pharmalys provides dedicated Project Managers who act as a seamless extension of your team. Fully integrated into your processes and systems, they collaborate closely with your CRAs, CTAs, vendors, and stakeholders. Support is scalable, from a single PM to coverage across multiple projects.

Why Choose Pharmalys Project Management?

  • Expert Teams: Certified and continuously trained to deliver excellence
  • Efficient Execution: Streamlined processes that keep projects on track
  • Local Insight, Global Standards: African regulatory know-how combined with international best practice
  • Proactive Risk & Quality Management: Ensuring compliance and data integrity
  • Client-Focused: Projects managed with your objectives at the centre

Contact us Today to learn more about how we can support your research!

World Neglected Tropical Diseases Day 2026 | 30 January

World Neglected Tropical Diseases Day 2026 | 30 January

Neglected tropical diseases remain a daily reality for more than one billion people worldwide. Yet they are among the most solvable challenges in global health. With proven tools, coordinated action, and sustained commitment, NTDs can be prevented, treated, and...

January 2026 Newsletter: Happy New Year from Pharmalys!

January 2026 Newsletter: Happy New Year from Pharmalys!

We hope you all enjoyed a restful festive period and feel energised for the year ahead. At Pharmalys, we enter 2026 with the same sense of readiness and purpose, having wrapped up 2025 with our Annual Meeting (pictured above), which provided an opportunity to reflect...

Strengthening GCLP Compliance at MSF Epicentre Laboratory, Mbarara

Strengthening GCLP Compliance at MSF Epicentre Laboratory, Mbarara

Pharmalys is pleased to announce the successful completion of a GCLP audit at the MSF Epicentre Laboratory in Mbarara, Uganda, conducted on 13-14 November 2025. Epicentre is a Médecins Sans Frontières (MSF) satellite dedicated to epidemiology, medical research, and...

Advancing GCLP Excellence at the UCL Cancer Institute, London

Advancing GCLP Excellence at the UCL Cancer Institute, London

We are pleased to announce the successful completion of a GCLP audit at the ECMC GCLP Facility, UCL Cancer Institute, University College London, carried out on 20-21 November 2025 as part of Pharmalys’ ongoing commitment to strengthening global Good Clinical...